Zobrazeno 1 - 10
of 183
pro vyhledávání: '"S, Saivin"'
Autor:
B. Georges, Dieye E, J. F. Decun, K. Samii, Georges Houin, Thierry Seguin, M. Lavit, J.M. Conil, S. Saivin, P. Cougot
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 46:157-164
Aim The purpose of our study was to define and validate a population-pharmacokinetic model including the influence of patients' characteristics on the pharmacokinetics of cefepime. Patients and methods A total of 55 patients were randomized in Group
Autor:
Georges Houin, K. Samii, J.M. Conil, I. Tack, B. Georges, Thierry Seguin, M. Lavit, G. Chabanon, S. Saivin
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 45:529-538
Aim The standard dosage recommendations for beta-lactam antibiotics can result in very low drug levels in intensive care (IC) patients and burn patients in the absence of renal dysfunction. We studied the pharmacokinetic parameters and serum concentr
Autor:
Kamran Samii, Georges Houin, I. Tack, S. Saivin, Jean-Marie Conil, M. Lavit, Thierry Seguin, Olivier Fourcade, Bernard Georges
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, Wiley, 2007, 63 (5), pp.583-94. ⟨10.1111/j.1365-2125.2006.02807.x⟩
British Journal of Clinical Pharmacology, 2007, 63 (5), pp.583-94. ⟨10.1111/j.1365-2125.2006.02807.x⟩
British Journal of Clinical Pharmacology, Wiley, 2007, 63 (5), pp.583-94. ⟨10.1111/j.1365-2125.2006.02807.x⟩
British Journal of Clinical Pharmacology, 2007, 63 (5), pp.583-94. ⟨10.1111/j.1365-2125.2006.02807.x⟩
International audience; WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: * In burn patients it has been shown ([2]), that there is a correlation between the creatinine clearance (CL(CR)) and the clearance of inulin. * The CL(CR) has never been studied in bu
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 45:133-142
Objective: The pharmacokinetics of ceftazidime, the antibiotic of choice for treating acute P. aeruginosa infections, may be modified in bums patients. The aim of this study was to identify the factors causing variations in the serum antibiotic conce
Publikováno v:
EMC - Biologie Médicale. 1:1-4
Autor:
P. Andrieu, E. Bonnet, G. Chabanon, P. Cougot, C. Virenque, K. Samii, M. Archambaud, G. Houin, J.M. Conil, B. Georges, J. F. Decun, B. Chaminade, S. Saivin, Ch Roche
Publikováno v:
Pathologie Biologie. 50:161-168
Resume Les glycopeptides representent le traitement de choix des infections severes a SAMR. La Vancomycine reste la reference. On peut cependant lui reprocher sa lenteur de bactericidie qui est de 24 a 48 heures. Objectif – Le but de cette etude pr
Autor:
M. Bardet-Neyrin, G. Houin, O. Bernard, V. Laumond, I. Delobbe-Fortner, S. Saivin, M.-J. Soum
Publikováno v:
Revue Française des Laboratoires. 1997:35-42
Resume La validation du kit Emit® 2000 Digoxine adapte sur automate Solaris a montre une precision et une inexactitude toujours inferieures a 20 % et une limite de quantification de 0.5 ng/ml soit 0.64 nmol/l. Une excellente correlation (r = 0.9795,
Autor:
S Saivin, A.M. Gabaig, Pierre Sie, Jean-Claude Lormeau, G Houin, Bernard Boneu, C. Caranobe, V. Peyrou, B. Crepon
Publikováno v:
Scopus-Elsevier
SummaryThis study compares some in vivo pharmacological properties of CY 216 and of its ACLM and BCLM components having a molecular weight above and below 5.4 kDa respectively. The anti-factor Xa/anti-thrombin ratio of these compounds determined in a
Autor:
Georges Houin, Jean-Marie Conil, Bernard Georges, Dalia Khachman, S. Saivin, Céline M. Laffont, Pierre-Louis Toutain
Publikováno v:
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2011, 66 (8), pp.1798-7809. ⟨10.1093/jac/dkr220⟩
Journal of Antimicrobial Chemotherapy 8 (66), 1798-7809. (2011)
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2011, 66 (8), pp.1798-7809. 〈10.1093/jac/dkr220 〉
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2011, 66 (8), pp.1798-7809. ⟨10.1093/jac/dkr220 ⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2011, 66 (8), pp.1798-7809. ⟨10.1093/jac/dkr220⟩
Journal of Antimicrobial Chemotherapy 8 (66), 1798-7809. (2011)
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2011, 66 (8), pp.1798-7809. 〈10.1093/jac/dkr220 〉
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2011, 66 (8), pp.1798-7809. ⟨10.1093/jac/dkr220 ⟩
Objectives: To explore different ciprofloxacin dosage regimens for the treatment of intensive care unit (ICU) patients with respect to clinical outcome and the development of bacterial resistance for the major Gramnegative pathogens. Methods: A popul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77ab3cd4e2b718e087aaf4611d4e2049
https://hal.archives-ouvertes.fr/hal-01191147
https://hal.archives-ouvertes.fr/hal-01191147
Autor:
Aurélie Prémaud, Guillaume Hoizey, Lionel Hary, Patricia Compagnon, C. Loichot, Alexandra Rousseau, Pierre Marquet, D. Debruyne, Evelyne Jacqz-Aigrain, S. Saivin, Nicolas Venisse, Y. Le Meur, Alain Turcant
Publikováno v:
Pharmacological Research
Pharmacological Research, 2010, 61 (2), pp.167-174. ⟨10.1016/j.phrs.2009.09.006⟩
Pharmacological Research, Elsevier, 2010, 61 (2), pp.167-174. ⟨10.1016/j.phrs.2009.09.006⟩
Pharmacological Research, 2010, 61 (2), pp.167-174. ⟨10.1016/j.phrs.2009.09.006⟩
Pharmacological Research, Elsevier, 2010, 61 (2), pp.167-174. ⟨10.1016/j.phrs.2009.09.006⟩
LDM TEP COLL; International audience; The aim of this study was to analyze retrospectively and critically the different steps of the individual dose adjustment procedure employed in the concentration-controlled (CC) versus fixed-dose trial Apomygre,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ab1cd611b90785e3260744ec2bc8e1e
https://univ-angers.hal.science/hal-03134625
https://univ-angers.hal.science/hal-03134625